Patients with nonmetastatic prostate cancer treated according to NCCN Guidelines are more likely to die of other natural ...

The NCCN Guidelines for Patients ® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation®.

The new interactive guideline tool represents a major format change for gold-standard NCCN Guidelines.

The National Comprehensive Cancer Network (NCCN)—an alliance of leading cancer centers—announces a new, interactive digital delivery format for the NCCN Clinical Practice Guidelines in ...

NCCN Clinical Practice Guidelines in Oncology Prostate Cancer The National Comprehensive Cancer Network issues updated guidelines for the diagnosis and management of prostate cancer.

NCCN Guidelines® recommend FES PET for systemic staging in certain patients with invasive lobular cancer (ILC), which could facilitate greater diagnostic accuracy, earlier interventions, better ...

Danyelza is now a recommended treatment in NCCN guidelines for relapsed or refractory high-risk neuroblastoma, a type of brain cancer.

In its updated guidelines for colon cancer 1 and for rectal cancer 2, NCCN now includes ctDNA as a high risk factor for recurrence in the adjuvant setting, recognizing its prognostic value.

Puma Biotechnology (PBYI) announced that the National Comprehensive Cancer Network, or NCCN, Clinical Practice Guidelines in Oncology for Cervical Cancer were updated to include an addition ...

The National Comprehensive Cancer Network (NCCN) - an alliance of leading cancer centers focusing on maintaining evidence-based expert consensus driven guidelines for care - announces the ...

Chronic myelomonocytic leukemia (CMML) is a rare type of blood cancer that usually affects older adults. The outlook will depend on the type. Learn more here.